SecBot SecBot

ZIVO

Zivo Bioscience, Inc.
OTC· Biological Products, (No Diagnostic Substances)· Inc. NV· CIK 0001101026 Biotech & Drug Discovery
$6.25 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $6.25
Next earnings
Nov 12
in 16 days
1 year
−57.0%
from $14.54 · Oct 27
30 days
+89.4%
from $3.30
52-week range
$1.17–17.00
−63% from high · low Apr 23
Avg volume 20D
745
Oct 9 spike 3.9K
Short interest
🔒 Subscribers only
Insider net
+$435.4K
2 buyers · 0 sellers · 12 mo

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Feb 10 to Feb 12 2 days of insider buys: $220.4K by 2 insiders, avg $9.02
  • B Feb 27 1 insider buy $15.0K at $9.72
  • B Apr 17 1 insider buy $200.0K at $2.00

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $435.4K at an average $3.51. No open-market sales. Price is 78% above their cost.

  • TrendUPTREND

    42% above its 50-day average.

Who's buying

13F
Top holderSharesValue
HUNTINGTON NATIONAL BANK104$702.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jun 2024
Recent actions
DateFirmActionRating
Jun 4, 2024Maxim Group
DOWNGRADE
DOWNGRADEHold

Insider ledger

Form 4
$435.4K
bought · 2 insiders
$0
sold · 0 insiders
+78.0%
vs their $3.51 cost
DateInsiderTypeValue
Apr 17, 2026
STROME MARK E
10%+ Owner
BUY$200.0K
Feb 27, 2026
YALDOO LAITH L
Director
BUY$15.0K
Feb 12, 2026
STROME MARK E
10%+ Owner
BUY$195.4K
Feb 12, 2026
STROME MARK E
10%+ Owner
BUY2,000 sh
Feb 10, 2026
YALDOO LAITH L
Director
BUY$25.0K

Earnings setup

Estimates
Nov 12
reports in 16 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 Earnings calendar
ZIVO Q2 2026 Earnings Scheduled — 2026-08-12
Apr 17, 2026 Insider
STROME MARK E bought 100,000 shares
10%+ Owner @ $2.00 ($200.0K)
Feb 27, 2026 Insider
YALDOO LAITH L bought 1,543 shares
Director @ $9.72 ($15.0K)
Feb 12, 2026 Insider
STROME MARK E bought 20,000 shares
10%+ Owner @ $9.77 ($195.4K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent